|Articles|July 6, 2015

Study Explains How Dengue Virus Adapts As It Travels, Increasing Chances for Outbreaks

A researcher from the University of Texas Medical Branch at Galveston is an integral member of a collaborative group that is the first to explain the mechanisms that the dengue virus has developed to optimize its ability to cause outbreaks as it travels across the globe to new places and revisits old ones. An early online version of this paper detailing the findings has recently been published in Science.

Dengue virus has been spreading throughout warm regions of the world, prompting the virus to adapt to new environments. This diversification in viral strains has resulted in the development of strains that appear associated with greater potential for sparking epidemics. Several dengue outbreaks have occurred when new dengue strains emerged and displaced the native strains that the local population had already developed immunity against. Until now, the mechanisms governing how and why some viral strains are better suited for causing widespread disease has been poorly understood.

The investigators examined the different clades of dengue virus-2 known to be circulating around Puerto Rico in 1994 when a severe epidemic broke out. Investigating the differences between the virus strain that was most commonly seen from 1986 to 1995 and a new, more potent viral strain that was first isolated in 1994 was the key to figuring out why this outbreak occurred.

They identified an interaction between the newcomer virus's RNA and proteins within the host that allows the virus to bypass the host's immune response, making it easier for the virus to invade. Based on the findings, the research team devised a model to explain the 1994 dengue outbreak in Puerto Rico.

"This study highlights the critical and oft forgotten role played by non-coding RNAs in the battle between viruses and their human hosts," says author Mariano Garcia-Blanco, UTMB professor and chair of the department of biochemistry and molecular biology and also professor of emerging infectious diseases at the Duke-NUS Graduate Medical School in Singapore. "It emphasizes the importance of multidisciplinary research: a fabulous marriage of basic RNA biology and clinically informed epidemiology uncovered an unexpected route of virus evolution that explained (and perhaps could predict) epidemic potential."

Other authors of this paper include Gayathri Manokaran, Esteban Finol, Jayantha Gunaratne, Eugenia Z. Ong, Hwee Cheng Tan, October M. Sessions, Alex M. Ward, Duane J. Gubler and corresponding author Eng Eong Ooi from the Duke-NUS Graduate Medical School; Chunling Wang, and Eva Harris from the University of California, Berkeley and Justin Bahl from the University of Texas School of Public Health, Houston.

This research was supported by the Singapore National Medical Research Council, the Ministry of Health in Singapore, Institute of Molecular and Cell Biology, Agency of Science, Technology and Research in Singapore and the U.S. National Institutes of Health.

Source: University of Texas Medical Branch at Galveston
 


Related to this article

Water  (Adobe Stock 456102510 by stockphoto-graf)
Understanding current water quality is a starting point for ST108 implementation. John Kimsey, vice president of processing optimization and customer success for STERISS, spoke about his HSPA presentation on assessing readiness, distinguishing system qualification from routine testing, and understanding where water samples should be collected.
Image of Pathogens flying   (Adobe Stock weerasak)
Behind every landmark in infection prevention, from antimicrobial stewardship guidelines to the COVID-19 town halls that reached flight attendants and teachers, is a generation of physician-scientists who led SHEA through crises, organizational change, and scientific breakthroughs. Infection Control Today traces 30 years of SHEA presidents and the lasting mark they left on the field.
AORN26 New Orleans 2026  (Adobe Stock)
Missing instruments and processing delays can strain OR–SPD relationships. At AORN 2026, John Kimsey, vice president of processing optimization and customer success for STERIS, discusses understanding root causes, exploring off-site reprocessing for ambulatory surgical centers, and using hands-on simulation to help surgical teams see sterile processing from a different perspective.